TITLE:
Heart Failure and Anemia

CONDITION:
Heart Failure

INTERVENTION:
Darbepoetin Alfa

SUMMARY:

      The purpose of this study is to determine whether increasing hemoglobin concentration in
      patients with heart failure and anemia will improve the patients' functional status,
      including exercise tolerance and New York Heart Association (NYHA) classification.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 21 Years to N/A
Criteria:

        Inclusion Criteria: - At least 21 years of age - Symptomatic CHF for at least 3 months -
        Limited exercise tolerance on a treadmill - Reduced left ventricular ejection fraction -
        Stable heart failure medication - Hemoglobin concentration between 9.0 and 12.5 g/dL
        Exclusion Criteria: - Hypertension - Unstable angina pectoris or recent myocardial
        infarction - Likely to receive cardiac transplant - Unable to do cardiopulmonary exercise
        testing - Major organ transplant (e.g., lung, liver, heart) or in renal replacement
        therapy (e.g., dialysis) - Recent or current treatment for malignancy - Systemic
        hematologic disease - Anemia due to acute or chronic bleeding - Recent epogen or
        darbepoetin alfa therapy - Recent blood transfusion
      
